Hence then, the article about gilgamesh pharmaceuticals awarded 14 million national institute on drug abuse grant to advance novel cardiac safe ibogaine analog for the treatment of opioid use disorder was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Gilgamesh Pharmaceuticals Awarded $14 Million National Institute on Drug Abuse Grant to Advance Novel, Cardiac-Safe Ibogaine Analog for the Treatment of Opioid Use Disorder )
Also on site :
- Cyberattack hits Canvas system used by thousands of schools as finals loom
- Leak points to insider who allegedly helped Zelensky crony escape justice – media
- Driving less, canceling vacations, and tightening budgets: All the ways Americans are coping with soaring gas prices